Insider Buy/Sell Details for the Healthcare Sector — June 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (2298)
Enliven Therapeutics, Inc. (ELVN)
Hohl Benjamin — CHIEF FINANCIAL OFFICER
Shares
3,401
Price
$43.86
Total Value
$149.18K
Shares Held After
52,238
% of Holdings
6.1%
Enliven Therapeutics, Inc. (ELVN)
Hohl Benjamin — CHIEF FINANCIAL OFFICER
Shares
1,379
Price
$42.78
Total Value
$59.00K
Shares Held After
55,639
% of Holdings
2.4%
Enliven Therapeutics, Inc. (ELVN)
Collins Helen Louise — CHIEF MEDICAL OFFICER
Shares
1,133
Price
$44.74
Total Value
$50.69K
Shares Held After
25,000
% of Holdings
4.3%
Enliven Therapeutics, Inc. (ELVN)
Collins Helen Louise — CHIEF MEDICAL OFFICER
Shares
2,599
Price
$43.87
Total Value
$114.02K
Shares Held After
26,133
% of Holdings
9.0%
Enliven Therapeutics, Inc. (ELVN)
Collins Helen Louise — CHIEF MEDICAL OFFICER
Shares
1,268
Price
$42.83
Total Value
$54.30K
Shares Held After
28,732
% of Holdings
4.2%
PTC THERAPEUTICS, INC. (PTCT)
Utter Christine Marie — SVP, CHIEF ACCOUNTING OFFICER
Shares
19,686
Price
$75.56
Total Value
$1.49M
Shares Held After
70,199
% of Holdings
21.9%
Tarsus Pharmaceuticals, Inc. (TARS)
Azamian Bobak R. — Director
Shares
5,418
Price
$61.81
Total Value
$334.89K
Shares Held After
847,991
% of Holdings
0.6%
Tarsus Pharmaceuticals, Inc. (TARS)
Azamian Bobak R. — Director
Shares
4,582
Price
$61.24
Total Value
$280.60K
Shares Held After
853,409
% of Holdings
0.5%
PALVELLA THERAPEUTICS, INC. (PVLA)
Goin Kathleen — Chief Operating Officer
Shares
25
Price
$112.23
Total Value
$2.81K
Shares Held After
0
% of Holdings
100.0%
PALVELLA THERAPEUTICS, INC. (PVLA)
Goin Kathleen — Chief Operating Officer
Shares
1,887
Price
$111.31
Total Value
$210.05K
Shares Held After
25
% of Holdings
98.7%
PALVELLA THERAPEUTICS, INC. (PVLA)
Goin Kathleen — Chief Operating Officer
Shares
2,390
Price
$110.26
Total Value
$263.52K
Shares Held After
1,912
% of Holdings
55.6%
Dyne Therapeutics, Inc. (DYN)
Kersten Dirk — Director
Shares
37,454
Price
$20.14
Total Value
$754.32K
Shares Held After
4,159,119
% of Holdings
0.9%
Canopy Growth Corp (CGC)
Gedeon Christelle — Chief Legal Officer and Corporate Secretary
Shares
58,994
Price
$0.97
Total Value
$57.47K
Shares Held After
705,506
% of Holdings
7.7%
Canopy Growth Corp (CGC)
Stewart Thomas Carlton — Chief Financial Officer and Chief Accounting Officer
Shares
9,285
Price
$0.97
Total Value
$9.04K
Shares Held After
616,398
% of Holdings
1.5%
Canopy Growth Corp (CGC)
Mongeau Luc — Director
Shares
135,231
Price
$0.97
Total Value
$131.73K
Shares Held After
1,723,913
% of Holdings
7.3%
ClearPoint Neuro, Inc. (CLPT)
BURNETT JOSEPH — Director
Shares
1,843
Price
$17.94
Total Value
$33.06K
Shares Held After
191,388
% of Holdings
1.0%
ClearPoint Neuro, Inc. (CLPT)
BURNETT JOSEPH — Director
Shares
60,000
Price
$17.79
Total Value
$1.07M
Shares Held After
116,842
% of Holdings
33.9%
Pasithea Therapeutics Corp. (KTTA)
Coastlands Capital LP — 10% Owner
Shares
100,000
Price
$0.53
Total Value
$53.00K
Shares Held After
3,835,035
% of Holdings
2.6%
uniQure N.V. (QURE)
Balachandran Madhavan — Director
Shares
1,690
Price
$42.60
Total Value
$71.99K
Shares Held After
43,254
% of Holdings
3.8%
uniQure N.V. (QURE)
Balachandran Madhavan — Director
Shares
4,700
Price
$43.66
Total Value
$205.20K
Shares Held After
44,944
% of Holdings
9.5%
uniQure N.V. (QURE)
Balachandran Madhavan — Director
Shares
5,295
Price
$47.08
Total Value
$249.29K
Shares Held After
49,644
% of Holdings
9.6%
uniQure N.V. (QURE)
Kaye Jack — Director
Shares
5,295
Price
$42.57
Total Value
$225.41K
Shares Held After
25,996
% of Holdings
16.9%
uniQure N.V. (QURE)
Kapusta Matthew C — Director
Shares
11,585
Price
$48.65
Total Value
$563.61K
Shares Held After
558,810
% of Holdings
2.0%
uniQure N.V. (QURE)
Kapusta Matthew C — Director
Shares
33,334
Price
$45.01
Total Value
$1.50M
Shares Held After
570,395
% of Holdings
5.5%
uniQure N.V. (QURE)
Kapusta Matthew C — Director
Shares
56,929
Price
$43.43
Total Value
$2.47M
Shares Held After
603,729
% of Holdings
8.6%
uniQure N.V. (QURE)
Kapusta Matthew C — Director
Shares
32,581
Price
$45.02
Total Value
$1.47M
Shares Held After
660,658
% of Holdings
4.7%
uniQure N.V. (QURE)
Kapusta Matthew C — Director
Shares
6,023
Price
$43.70
Total Value
$263.21K
Shares Held After
693,239
% of Holdings
0.9%
uniQure N.V. (QURE)
Kapusta Matthew C — Director
Shares
23,977
Price
$42.61
Total Value
$1.02M
Shares Held After
699,262
% of Holdings
3.3%
Nasus Pharma Ltd (NSRX)
Teleman Dan Benjamin — Director
Shares
6,550
Price
$3.10
Total Value
$20.30K
Shares Held After
163,541
% of Holdings
4.0%
BioCardia, Inc. (BCDA)
Altman Peter — Director
Shares
1,500
Price
$0.85
Total Value
$1.27K
Shares Held After
299,766
% of Holdings
0.5%
NEKTAR THERAPEUTICS (NKTR)
ROBIN HOWARD W — Director
Shares
4,500
Price
$61.65
Total Value
$277.43K
Shares Held After
55,045
% of Holdings
7.6%
NEKTAR THERAPEUTICS (NKTR)
ROBIN HOWARD W — Director
Shares
5,500
Price
$60.81
Total Value
$334.45K
Shares Held After
59,545
% of Holdings
8.5%
Mirum Pharmaceuticals, Inc. (MIRM)
Howe Jolanda — SVP, GLOBAL CONTROLLER
Shares
2,594
Price
$101.95
Total Value
$264.46K
Shares Held After
5,835
% of Holdings
30.8%
Cadrenal Therapeutics, Inc. (CVKD)
Pham Quang X — Director
Shares
513
Price
$3.16
Total Value
$1.62K
Shares Held After
128,589
% of Holdings
0.4%
Crinetics Pharmaceuticals, Inc. (CRNX)
Okey Stephanie — Director
Shares
608
Price
$36.22
Total Value
$22.02K
Shares Held After
6,400
% of Holdings
8.7%
Crinetics Pharmaceuticals, Inc. (CRNX)
Okey Stephanie — Director
Shares
6,292
Price
$35.62
Total Value
$224.12K
Shares Held After
7,008
% of Holdings
47.3%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
Veness Adam M — SVP, General Counsel and Sec.
Shares
13,229
Price
$81.38
Total Value
$1.08M
Shares Held After
0
% of Holdings
100.0%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
Veness Adam M — SVP, General Counsel and Sec.
Shares
16,771
Price
$80.34
Total Value
$1.35M
Shares Held After
13,229
% of Holdings
55.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
574
Price
$555.63
Total Value
$318.93K
Shares Held After
40,513
% of Holdings
1.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,909
Price
$554.77
Total Value
$1.06M
Shares Held After
41,087
% of Holdings
4.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,201
Price
$553.78
Total Value
$665.09K
Shares Held After
42,996
% of Holdings
2.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
727
Price
$552.75
Total Value
$401.85K
Shares Held After
44,197
% of Holdings
1.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,840
Price
$551.73
Total Value
$1.02M
Shares Held After
44,924
% of Holdings
3.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,077
Price
$550.87
Total Value
$1.14M
Shares Held After
46,764
% of Holdings
4.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
612
Price
$549.57
Total Value
$336.34K
Shares Held After
48,841
% of Holdings
1.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
560
Price
$548.57
Total Value
$307.20K
Shares Held After
49,453
% of Holdings
1.1%
CORCEPT THERAPEUTICS INC (CORT)
MAHONEY DAVID L — Director
Shares
20,000
Price
$84.53
Total Value
$1.69M
Shares Held After
26,147
% of Holdings
43.3%
Esperion Therapeutics, Inc. (ESPR)
Looker Benjamin — Chief Legal Officer
Shares
11,824
Price
$3.15
Total Value
$37.30K
Shares Held After
667,524
% of Holdings
1.7%
Esperion Therapeutics, Inc. (ESPR)
Koenig Sheldon L. — Director
Shares
53,588
Price
$3.15
Total Value
$169.07K
Shares Held After
2,119,111
% of Holdings
2.5%
Esperion Therapeutics, Inc. (ESPR)
Halladay Benjamin — Chief Financial Officer
Shares
10,773
Price
$3.15
Total Value
$33.99K
Shares Held After
702,829
% of Holdings
1.5%
Showing 901–950 of 2298 transactions (page 19 of 46)